Metagenomi advances MGX-001 toward IND filing
Metagenomi said MGX-001 has preclinical durability and safety data and plans to file an IND in Q4 2026. The company said it had $120.7 million of cash runway through Q4 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.